ClomiPHENE Citrate Tablets recall: CGMP Deviations
ClomiPHENE Citrate Tablets, USP 50 mg, 30-count bottle, Rx only, MFG: PAR Pharma, NDC 49884-701-55
Why was ClomiPHENE Citrate Tablets recalled?
cGMP deviations: Temperature abuse
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
- Product
- ClomiPHENE Citrate Tablets, USP 50 mg, 30-count bottle, Rx only, MFG: PAR Pharma, NDC 49884-701-55
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office
- Quantity
- 240 cartons/3 blister packs per carton
- Distribution
- USA nationwide.
- Recall date
- June 15, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)